By Adriano Marchese

 

Proteome Sciences PLC said Wednesday that it has been issued a U.S. patent covering the company's TMTcalibrator workflow, relating to methods of analysis.

The protein-biomarker research company said the patent issuance enables enhanced fluid biomarker discovery and single-cell proteomics and forms part of the intellectual property exclusively licensed to Thermo Fisher Scientific Inc. by the company.

"[It] is a key patent covering our TMTcalibrator technology, which is at the heart of our precision medicine efforts," Chief Scientific Officer Ian Pike said.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

May 19, 2021 13:31 ET (17:31 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De Nov 2021 a Dic 2021 Haga Click aquí para más Gráficas Proteome Sciences.
Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De Dic 2020 a Dic 2021 Haga Click aquí para más Gráficas Proteome Sciences.